Trademark: 88503732
Status Date
Monday, February 6, 2023
Filing Date
Monday, July 8, 2019
Published for Opposition
Tuesday, November 5, 2019
Abandoned Date
Monday, February 6, 2023
5 Pain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain, including lumbosacral radicular pain and sciatica; dexamethasone sodium phosphate for medical use for use in the treatment of pain; dexamethasone sodium phosphate gel for medical use
Feb 6, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 6, 2023
Abandonment - No Use Statement Filed
May 25, 2022
Notice Of Approval Of Extension Request E-Mailed
May 24, 2022
Sou Extension 5 Granted
May 20, 2022
Sou Extension 5 Filed
May 24, 2022
Case Assigned To Intent To Use Paralegal
May 20, 2022
Teas Extension Received
Dec 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2021
Sou Extension 4 Granted
Dec 17, 2021
Sou Extension 4 Filed
Dec 17, 2021
Teas Extension Received
Jun 22, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 18, 2021
Sou Extension 3 Granted
Jun 18, 2021
Sou Extension 3 Filed
Jun 18, 2021
Teas Extension Received
Oct 23, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 21, 2020
Sou Extension 2 Granted
Oct 21, 2020
Sou Extension 2 Filed
Oct 21, 2020
Teas Extension Received
Jul 2, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 30, 2020
Sou Extension 1 Granted
Jun 30, 2020
Sou Extension 1 Filed
Jun 30, 2020
Teas Extension Received
Dec 31, 2019
Noa E-Mailed - Sou Required From Applicant
Nov 5, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 5, 2019
Published For Opposition
Oct 16, 2019
Notification Of Notice Of Publication E-Mailed
Sep 26, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 26, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 25, 2019
Approved For Pub - Principal Register
Sep 24, 2019
Assigned To Examiner
Jul 16, 2019
New Application Office Supplied Data Entered
Jul 11, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24